BLRX
Price:
$3.37
Market Cap:
$14.29M
BioLineRx Ltd., an Israeli biopharmaceutical firm established in 2003 and based in Hevel Modi'in, focuses its clinical-stage development efforts primarily on oncology. Their leading investigational product, Motixafortide, a peptide, has successfully concluded pivotal Phase 3 clinical trials for mobilizing stem cells in autologous transplants, and Phase 2a trials targeting pancreatic cancer. This compound is currently progressing through Phase 2 studies for metastatic pancreatic adenocarcinoma and Phase 1b trials for acute respiratory distress syndrome linked to COVID-19 and other viral infections. Additionally, Motixafortide is being investigated for its therapeutic potential in solid tumors...[Read more]
Industry
Biotechnology
IPO Date
2011-07-27
Stock Exchange
NASDAQ
Ticker
BLRX
According to BioLineRx Ltd.’s latest financial reports and current stock price. The company's current Enterprise Value is 20.85M. This represents a change of 3.74% compared to the average of 20.10M of the last 4 quarters.
The mean historical Enterprise Value of BioLineRx Ltd. over the last ten years is 53.46M. The current 20.85M Enterprise Value has changed 3.80% with respect to the historical average. Over the past ten years (40 quarters), BLRX's Enterprise Value was at its highest in in the December 2023 quarter at 123.94M. The Enterprise Value was at its lowest in in the March 2025 quarter at 13.80M.
Average
53.46M
Median
42.97M
Minimum
19.28M
Maximum
111.50M
Discovering the peaks and valleys of BioLineRx Ltd. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 207.45%
Maximum Annual Enterprise Value = 111.50M
Minimum Annual Increase = -76.70%
Minimum Annual Enterprise Value = 19.28M
| Year | Enterprise Value | Change |
|---|---|---|
| 2025 | 19.28M | -25.78% |
| 2024 | 25.98M | -76.70% |
| 2023 | 111.50M | 207.45% |
| 2022 | 36.27M | -56.74% |
| 2021 | 83.83M | 145.22% |
| 2020 | 34.18M | 22.41% |
| 2019 | 27.92M | -47.01% |
| 2018 | 52.70M | -43.46% |
| 2017 | 93.22M | 87.63% |
| 2016 | 49.68M | -20.34% |
The current Enterprise Value of BioLineRx Ltd. (BLRX) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
52.25M
5-year avg
55.37M
10-year avg
53.46M
BioLineRx Ltd.’s Enterprise Value is less than Tharimmune, Inc. (66.84M), greater than GeoVax Labs, Inc. (292.14K), less than Adaptimmune Therapeutics plc (31.10M), greater than Apollomics, Inc. (13.15M), less than Adlai Nortye Ltd. (550.38M), greater than Aditxt, Inc. (3.97M), greater than Moleculin Biotech, Inc. (3.96M), greater than Ainos, Inc. (16.81M), greater than SeaStar Medical Holding Corporation (-559927.00), greater than Lunai Bioworks Inc. (9.18M),
| Company | Enterprise Value | Market cap |
|---|---|---|
| 66.84M | $139.94M | |
| 292.14K | $1.17M | |
| 31.10M | $75.16M | |
| 13.15M | $15.78M | |
| 550.38M | $547.79M | |
| 3.97M | $425.00 | |
| 3.96M | $14.09M | |
| 16.81M | $8.65M | |
| -559927.00 | $8.46M | |
| 9.18M | $10.93M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like BioLineRx Ltd. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like BioLineRx Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is BioLineRx Ltd.'s Enterprise Value?
What is the highest Enterprise Value for BioLineRx Ltd. (BLRX)?
What is the 3-year average Enterprise Value for BioLineRx Ltd. (BLRX)?
What is the 5-year average Enterprise Value for BioLineRx Ltd. (BLRX)?
How does the current Enterprise Value for BioLineRx Ltd. (BLRX) compare to its historical average?